Why Is the FDA Expediting an RSV mRNA Vaccine?

Oh, boy, here we go again! Is a respiratory syncytial virus (RSV) mRNA vaccine something that really needs to be fast-tracked? Why can’t the FDA follow its normal vaccine safety process for mRNA ‘vaccine’ evaluations? This smells of regulatory capture. This wreaks of vaccine companies rushing to promote a “new” and under-evaluated medical technology to […]